1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Central Nervous System Drug Market Professional Survey Report 2016

This report
Mainly covers the following product types
Sedative-hypnotics
Antiepileptics
Antipsychotic Drugs
Antidepressants
Analgesics
Drugs for Neurodegeneration Disease
The segment applications including
Segment regions including (the separated region report can also be offered)
USA
China
Europe
South America
Japan
Africa
The players list (Partly, Players you are interested in can also be added)
Johnson & Johnson
Pfizer
Novartis
Roche
Sanofi
Merck
GSK
Bayer
Bristol-Myers Squibb
AbbVie
Eli Lilly
AstraZeneca
Takeda
Actavis
Astellas
Teva
Biogen
Shire
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Kg and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/g, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!


Table Of Contents

Global Central Nervous System Drug Market Professional Survey Report 2016
Table of Contents

1 Industry Overview of Central Nervous System Drug
1.1 Definition and Specifications of Central Nervous System Drug
1.1.1 Definition of Central Nervous System Drug
1.1.2 Specifications of Central Nervous System Drug
1.2 Classification of Central Nervous System Drug
1.2.1 Sedative-hypnotics
1.2.2 Antiepileptics
1.2.3 Antipsychotic Drugs
1.2.4 Antidepressants
1.2.5 Analgesics
1.2.6 Drugs for Neurodegeneration Disease
1.3 Applications of Central Nervous System Drug
1.4 Industry Chain Structure of Central Nervous System Drug
1.5 Industry Overview and Major Regions Status of Central Nervous System Drug
1.5.1 Industry Overview of Central Nervous System Drug
1.5.2 Global Major Regions Status of Central Nervous System Drug
1.6 Industry Policy Analysis of Central Nervous System Drug
1.7 Industry News Analysis of Central Nervous System Drug

2 Manufacturing Cost Structure Analysis of Central Nervous System Drug
2.1 Raw Material Suppliers and Price Analysis of Central Nervous System Drug
2.2 Equipment Suppliers and Price Analysis of Central Nervous System Drug
2.3 Labor Cost Analysis of Central Nervous System Drug
2.4 Other Costs Analysis of Central Nervous System Drug
2.5 Manufacturing Cost Structure Analysis of Central Nervous System Drug
2.6 Manufacturing Process Analysis of Central Nervous System Drug

3 Technical Data and Manufacturing Plants Analysis of Central Nervous System Drug
3.1 Capacity and Commercial Production Date of Global Central Nervous System Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Central Nervous System Drug Major Manufacturers in 2015
3.3 RandD Status and Technology Source of Global Central Nervous System Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Central Nervous System Drug Major Manufacturers in 2015

4 Global Central Nervous System Drug Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Central Nervous System Drug Capacity and Growth Rate Analysis
4.2.2 2015 Central Nervous System Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Central Nervous System Drug Sales and Growth Rate Analysis
4.3.2 2015 Central Nervous System Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Central Nervous System Drug Sales Price
4.4.2 2015 Central Nervous System Drug Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Central Nervous System Drug Gross Margin
4.5.2 2015 Central Nervous System Drug Gross Margin Analysis (Company Segment)

5 Central Nervous System Drug Regional Market Analysis
5.1 USA Central Nervous System Drug Market Analysis
5.1.1 USA Central Nervous System Drug Market Overview
5.1.2 USA 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Central Nervous System Drug Sales Price Analysis
5.1.4 USA 2015 Central Nervous System Drug Market Share Analysis
5.2 China Central Nervous System Drug Market Analysis
5.2.1 China Central Nervous System Drug Market Overview
5.2.2 China 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Central Nervous System Drug Sales Price Analysis
5.2.4 China 2015 Central Nervous System Drug Market Share Analysis
5.3 Europe Central Nervous System Drug Market Analysis
5.3.1 Europe Central Nervous System Drug Market Overview
5.3.2 Europe 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Central Nervous System Drug Sales Price Analysis
5.3.4 Europe 2015 Central Nervous System Drug Market Share Analysis
5.4 South America Central Nervous System Drug Market Analysis
5.4.1 South America Central Nervous System Drug Market Overview
5.4.2 South America 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 South America 2011-2016E Central Nervous System Drug Sales Price Analysis
5.4.4 South America 2015 Central Nervous System Drug Market Share Analysis
5.5 Japan Central Nervous System Drug Market Analysis
5.5.1 Japan Central Nervous System Drug Market Overview
5.5.2 Japan 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Central Nervous System Drug Sales Price Analysis
5.5.4 Japan 2015 Central Nervous System Drug Market Share Analysis
5.6 Africa Central Nervous System Drug Market Analysis
5.6.1 Africa Central Nervous System Drug Market Overview
5.6.2 Africa 2011-2016E Central Nervous System Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Africa 2011-2016E Central Nervous System Drug Sales Price Analysis
5.6.4 Africa 2015 Central Nervous System Drug Market Share Analysis

6 Global 2011-2016E Central Nervous System Drug Segment Market Analysis (by Type)
6.1 Global 2011-2016E Central Nervous System Drug Sales by Type
6.2 Different Types Central Nervous System Drug Product Interview Price Analysis
6.3 Different Types Central Nervous System Drug Product Driving Factors Analysis
6.3.1 Sedative-hypnotics Central Nervous System Drug Growth Driving Factor Analysis
6.3.2 Antiepileptics Central Nervous System Drug Growth Driving Factor Analysis
6.3.3 Antipsychotic Drugs Central Nervous System Drug Growth Driving Factor Analysis
6.3.4 Antidepressants Central Nervous System Drug Growth Driving Factor Analysis
6.3.5 Analgesics Central Nervous System Drug Growth Driving Factor Analysis
6.3.6 Drugs for Neurodegeneration Disease Central Nervous System Drug Growth Driving Factor Analysis

7 Global 2011-2016E Central Nervous System Drug Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis

8 Major Manufacturers Analysis of Central Nervous System Drug
8.1 Johnson and Johnson
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Johnson and Johnson 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Johnson and Johnson 2015 Central Nervous System Drug Business Region Distribution Analysis
8.2 Pfizer
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Pfizer 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Pfizer 2015 Central Nervous System Drug Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Novartis 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2015 Central Nervous System Drug Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Roche 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2015 Central Nervous System Drug Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Sanofi 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2015 Central Nervous System Drug Business Region Distribution Analysis
8.6 Merck
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Merck 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck 2015 Central Nervous System Drug Business Region Distribution Analysis
8.7 GSK
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 GSK 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 GSK 2015 Central Nervous System Drug Business Region Distribution Analysis
8.8 Bayer
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Bayer 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bayer 2015 Central Nervous System Drug Business Region Distribution Analysis
8.9 Bristol-Myers Squibb
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Bristol-Myers Squibb 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Bristol-Myers Squibb 2015 Central Nervous System Drug Business Region Distribution Analysis
8.10 AbbVie
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 AbbVie 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 AbbVie 2015 Central Nervous System Drug Business Region Distribution Analysis
8.11 Eli Lilly
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Eli Lilly 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Eli Lilly 2015 Central Nervous System Drug Business Region Distribution Analysis
8.12 AstraZeneca
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 AstraZeneca 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 AstraZeneca 2015 Central Nervous System Drug Business Region Distribution Analysis
8.13 Takeda
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Takeda 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Takeda 2015 Central Nervous System Drug Business Region Distribution Analysis
8.14 Actavis
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Actavis 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Actavis 2015 Central Nervous System Drug Business Region Distribution Analysis
8.15 Astellas
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Astellas 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Astellas 2015 Central Nervous System Drug Business Region Distribution Analysis
8.16 Teva
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Teva 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Teva 2015 Central Nervous System Drug Business Region Distribution Analysis
8.17 Biogen
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Biogen 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Biogen 2015 Central Nervous System Drug Business Region Distribution Analysis
8.18 Shire
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Shire 2015 Central Nervous System Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Shire 2015 Central Nervous System Drug Business Region Distribution Analysis

9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Central Nervous System Drug Consumption Forecast
9.2.2 China 2016-2021 Central Nervous System Drug Consumption Forecast
9.2.3 Europe 2016-2021 Central Nervous System Drug Consumption Forecast
9.2.4 South America 2016-2021 Central Nervous System Drug Consumption Forecast
9.2.5 Japan 2016-2021 Central Nervous System Drug Consumption Forecast
9.2.6 Africa 2016-2021 Central Nervous System Drug Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 Central Nervous System Drug Marketing Model Analysis
10.1 Central Nervous System Drug Regional Marketing Model Analysis
10.2 Central Nervous System Drug International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Central Nervous System Drug by Regions
10.4 Central Nervous System Drug Supply Chain Analysis

11 Consumers Analysis of Central Nervous System Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…

12 New Project Investment Feasibility Analysis of Central Nervous System Drug
12.1 New Project SWOT Analysis of Central Nervous System Drug
12.2 New Project Investment Feasibility Analysis of Central Nervous System Drug

13 Conclusion of the Global Central Nervous System Drug Market Professional Survey Report 2016


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5595
  • Industry report
  • October 2016
  • by Transparency Market Research

Radiopharmaceutical Market: Scope and Trends This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development ...

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Refurbished medical equipment market is being primarily driven by factors like development of e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing demand for refurbished ...

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.